OUTCOMES OF AN INTRAVITREAL INJECTION CLINIC.

Atchison, Elizabeth A; Omar, Ahmed F; Iezzi, Raymond; Barkmeier, Andrew J; Bakri, Sophie J

Atchison, Elizabeth A; Omar, Ahmed F; Iezzi, Raymond; Barkmeier, Andrew J; Bakri, Sophie J.

Affiliation

Atchison EA; Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota.

Retina ; 37(7): 1371-1376, 2017 Jul.

Article in En | MEDLINE | ID: mdl-27759581

Subject(s)

Bevacizumab/administration & dosage; Hospitals, Special; Ranibizumab/administration & dosage; Visual Acuity; Wet Macular Degeneration/drug therapy; Aged; Aged, 80 and over; Angiogenesis Inhibitors/administration & dosage; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Intravitreal Injections; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A/antagonists & inhibitors; Wet Macular Degeneration/diagnosis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Visual Acuity / Wet Macular Degeneration / Bevacizumab / Ranibizumab / Hospitals, Special Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2017 Type: Article

Fulltext

XML

PubMed Links

Search on Google